Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Plans underway to expand screening capacity by 50% for greater accessibility
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Subcutaneous nivolumab has potential to be the first and only subcutaneously administered PD-1 inhibitor
Subscribe To Our Newsletter & Stay Updated
_256_384.JPG)
